SCHEMBL844741

SCHEMBL844741

CCCC(=O)N1CC=C[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3C=CCN3C(=O)CC)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
MAPT P10636 6/20 0.38
KDM4E B2RXH2 2/20 0.38
ACE P12821 1/20 0.37
NAMPT P43490 2/20 0.35
RAB9A P51151 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
MAPK1 P28482 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845214 0.94 ITGB1 (0.39) ITGB1ITGA4MAPTKDM4EACE
SCHEMBL845097 0.82 NAMPT (0.39) ITGB1ITGA4MAPTKDM4ENAMPT
SCHEMBL845328 0.78 NAMPT (0.35) ITGB1ITGA4MAPTKDM4ENAMPT
SCHEMBL845099 0.77 ITGB1 (0.44) ITGB1ITGA4MAPTKDM4EKMT2A
SCHEMBL845331 0.77 PTPN1 (0.41) MAPTKDM4ENAMPTRAB9AKMT2A
SCHEMBL845098 0.76 ITGB1 (0.43) ITGB1ITGA4MAPTKDM4ERAB9A
SCHEMBL845190 0.74 EPHX2 (0.42) ITGB1ITGA4RAB9AKMT2AMEN1
SCHEMBL845622 0.74 ITGB1 (0.42) ITGB1ITGA4NAMPTPDE3B
SCHEMBL845086 0.74 EPHX2 (0.40) ITGB1ITGA4MAPTKDM4ERAB9A
SCHEMBL13272437 0.74 ITGB1 (0.32) ITGB1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed